-
June 25, 2019PREVIEW
According to a study published in the Journal of Patient Safety, implementation of a real-time clinical surveillance tool that provided alerts to pharmacists across 31 hospitals resulted...
-
April 16, 2019PREVIEW
Use of apixaban (Eliquis—Bristol-Myers Squibb, Pfizer) as thromboprophylaxis in intermediate- to high-risk ambulatory patients receiving chemotherapy for various types of cancers reduced the risk...
-
February 11, 2019PREVIEW
Use of apixaban (Eliquis—Bristol–Myers Squibb, Pfizer) appears to be more effective than rivaroxaban (Xarelto—Janssen) for prevention of recurrent venous thromboembolism (VTE) with a decreased...
-
January 22, 2019PREVIEW
In November 2018, the American Society of Hematology (ASH) released 6 of 10 chapters that summarize clinical practice guidelines on management of venous thromboembolism (VTE). One guideline...
-
December 11, 2018PREVIEW
Use of aspirin prophylaxis for patients undergoing a total knee arthroplasty (TKA) to prevent venous thromboembolism (VTE) was noninferior to other anticoagulant chemoprophylactic regimens....
Pages
